Drug List 171-180

Question 1

Avodart

Answer 1

Dutasteride

Type I and II 5A – reductase inhibitor

BPH as monotherapy to improve symptoms and reduce risks of acute urinary retention and need for prostate surgery; or in combination of tamsulosin

Question 2

Viagra

Answer 2

Sildenafil

Phosphodiesterase type 5 inhibitor (cGMP - specific)

Erectile dysfunction

Question 3

Cialis

Answer 3

Tadalafil

Phosphodiesterase type 5 inhibitor (cGMP - specific)

Erectile dysfunction

Question 4

Levitra

Answer 4

Vardenafil

Phosphodiesterase type 5 inhibitor (cGMP - specific)

Erectile dysfunction

Question 5

Adipex

Answer 5

Phentermine

Sympathomimetric

Short-term monotherapy as adjunct in management of
exogenous obesity in patients with initial body mass
greater than or equal to 30kg/m2, or greater than or equal to 27kg/m2 in presence of other risk factors.

Question 6

Accupril

Answer 6

Quinapril

Angiotensin-converting enzyme (ACE) inhibitor

HTN and CHS

Question 7

Altace

Answer 7

Ramiphil

Angiotensin-converting enzyme (ACE) inhibitor

HTN and CHF

Question 8

Avalide

Answer 8

Irbesartan & HCTZ

Angiotensin (II) receptor antagonist diuretic

HTN

Question 9

Avapro

Answer 9

Irbesartan

Angiotensin (II) receptor antagonist

HTN

Question 10

Benicar HCT

Answer 10

Olmesartant HCTZ

Angiotensin (II) receptor antagonist and thiazide diuretic

HTN and CHS